Patrice Hemon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Patrice Hemon has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Bozec
Institut Universitaire de la Face et du Cou, Centre Antoine Lacassagne, 33 Avenue de Valombrose, 06189 Nice, France
17 shared publications - Alizé Gouleau
Université Côte d’Azur, CNRS UMR7275, INSERM U1323, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France
17 shared publications - Anne Sudaka
Université Côte d’Azur, CNRS UMR7275, INSERM U1323, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France
17 shared publications - Axel Elaldi
VIDA Center, Computer Science and Engineering, New York University, New York, New York
17 shared publications - Aïda Meghraoui
Sorbonne Université, INSERM, CNRS, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France
17 shared publications - Fabienne Anjuère
Université Côte d'Azur, CNRS UMR7275, Inserm U1323, IPMC, Valbonne, France
17 shared publications
Latest Publications
- 19 October 2026
- Published by Elsevier in Laboratory Investigation
- Vol. 106 (12)
Advancing Multiplex Imaging: A Sequential Antigen Retrieval Protocol to Enhance Antibody Compatibility and Detection Sensitivity
- 19 October 2026
- Published by Elsevier in Laboratory Investigation
- Vol. 106 (12)
Advancing Multiplex Imaging: A Sequential Antigen Retrieval Protocol to Enhance Antibody Compatibility and Detection Sensitivity
- Open Access
AltraFlowSOM: A Semi-Supervised Framework for Imaging Mass Cytometry Phenotyping
Imaging Mass Cytometry (IMC) enables the simultaneous quantification of 40+ protein markers at single cell resolution in tissue, however biologically faithful phenotyping at scale remains a critical bottleneck. Unsupervised clustering fragments coherent populations or conversely merges biologically incoherent ones into a single cluster, supervised classifiers impose a closed vocabulary, and the presence of rare subsets (encoding clinically relevant biology) in conjunction with abundant subsets may be detrimental to detection performances. We present AltraFlowSOM, a semi-supervised extension of FlowSOM that embeds partial expert annotations directly into self-organizing map training via a two-layer SuperSOM architecture, balancing label-guided topology anchoring with unsupervised discovery. By anchoring the map to biologically labelled reference points, AltraFlowSOM circumvents the canonical dependency between batch correction and clustering. Evaluated under Leave-one-out cross validation on two independent IMC cohorts, Lupus Nephritis (n=22 ROIs) and Sjögren syndrome (n=10 ROIs), AltraFlowSOM outperformed all unsupervised and supervised baseline on Adjusted Rand Index, F1 scores (macro and weighted), weighted purity and in the identification of rare populations. The median Treg cell recovery exceeded that of all comparator methods. AltraFlowSOM resolves the scalability-alignment-discovery trilemma, by establishing a semi-supervised SOM as a generalizable method for high dimensional IMC phenotyping.
Open AccessAltraFlowSOM: A Semi-Supervised Framework for Imaging Mass Cytometry Phenotyping
Imaging Mass Cytometry (IMC) enables the simultaneous quantification of 40+ protein markers at single cell resolution in tissue, however biologically faithful phenotyping at scale remains a critical bottleneck. Unsupervised clustering fragments coherent populations or conversely merges biologically incoherent ones into a single cluster, supervised classifiers impose a closed vocabulary, and the presence of rare subsets (encoding clinically relevant biology) in conjunction with abundant subsets may be detrimental to detection performances. We present AltraFlowSOM, a semi-supervised extension of FlowSOM that embeds partial expert annotations directly into self-organizing map training via a two-layer SuperSOM architecture, balancing label-guided topology anchoring with unsupervised discovery. By anchoring the map to biologically labelled reference points, AltraFlowSOM circumvents the canonical dependency between batch correction and clustering. Evaluated under Leave-one-out cross validation on two independent IMC cohorts, Lupus Nephritis (n=22 ROIs) and Sjögren syndrome (n=10 ROIs), AltraFlowSOM outperformed all unsupervised and supervised baseline on Adjusted Rand Index, F1 scores (macro and weighted), weighted purity and in the identification of rare populations. The median Treg cell recovery exceeded that of all comparator methods. AltraFlowSOM resolves the scalability-alignment-discovery trilemma, by establishing a semi-supervised SOM as a generalizable method for high dimensional IMC phenotyping.
- Open Access
- 12 August 2026
- Published by Springer Nature in Cell Death & Differentiation
- p. 1-17
Spatial and functional characterization of ER stress proteins links fibroblast plasticity and proliferative processes in human osteoarthritic synovitis
A strong crosstalk exists between endoplasmic reticulum (ER) stress and synovitis. Beyond their canonical role in protein folding, ER stress chaperones may promote inflammation, cell survival, and fibroblast activation under pathological conditions. This study aimed at localizing and quantifying 11 ER stress proteins (BiP, HYOU1, MANF, PDIA4, GANAB, HSP90B1, TXNDC5, DNAJB11, LMAN1, ERP29, CALR) in human inflamed synovial membranes and at investigating their expression in fibroblast-like synoviocytes (FLS) under ER stress, pro-inflammatory, or pro-fibrotic stimuli. By immunohistochemistry, on a first cohort of formalin-fixed paraffin-embedded (FFPE) biopsies obtained from patients with osteoarthritis (OA), chronic pyrophosphate arthropathy (CPPA), and rheumatoid arthritis (RA), these ER chaperones were primarily localized to the lining in low-grade inflammation (Tak - FLS during inflammation. These observations were confirmed by immunofluorescence on a larger cohort of OA patients. As inflammation progresses, there is a loss of co-expression with CD55 in the lining, accompanied by a gradual shift towards co-expression with CD34 in the sublining. In vitro, ER stress proteins, particularly BiP, HYOU1, MANF, PDIA4, HSP90B1, LMAN1, CALR, and DNAJB11 are overexpressed in human OA FLS following ER stress, pro-inflammatory or pro-fibrotic stimulation, with BiP, PDIA4, HSP90B1, ERP29, and CALR also being secreted. PDIA4 emerged as a central player: its depletion significantly impaired FLS proliferation and migration, highlighting a direct role in driving synovitis. This study provides the first spatial and functional characterization of ER chaperones in human arthritic synovium, linking ER stress to fibroblast plasticity, inflammation, and fibrosis.
- 12 August 2026
- Published by Springer Nature in Cell Death & Differentiation
- p. 1-17
Open AccessSpatial and functional characterization of ER stress proteins links fibroblast plasticity and proliferative processes in human osteoarthritic synovitis
A strong crosstalk exists between endoplasmic reticulum (ER) stress and synovitis. Beyond their canonical role in protein folding, ER stress chaperones may promote inflammation, cell survival, and fibroblast activation under pathological conditions. This study aimed at localizing and quantifying 11 ER stress proteins (BiP, HYOU1, MANF, PDIA4, GANAB, HSP90B1, TXNDC5, DNAJB11, LMAN1, ERP29, CALR) in human inflamed synovial membranes and at investigating their expression in fibroblast-like synoviocytes (FLS) under ER stress, pro-inflammatory, or pro-fibrotic stimuli. By immunohistochemistry, on a first cohort of formalin-fixed paraffin-embedded (FFPE) biopsies obtained from patients with osteoarthritis (OA), chronic pyrophosphate arthropathy (CPPA), and rheumatoid arthritis (RA), these ER chaperones were primarily localized to the lining in low-grade inflammation (Tak - FLS during inflammation. These observations were confirmed by immunofluorescence on a larger cohort of OA patients. As inflammation progresses, there is a loss of co-expression with CD55 in the lining, accompanied by a gradual shift towards co-expression with CD34 in the sublining. In vitro, ER stress proteins, particularly BiP, HYOU1, MANF, PDIA4, HSP90B1, LMAN1, CALR, and DNAJB11 are overexpressed in human OA FLS following ER stress, pro-inflammatory or pro-fibrotic stimulation, with BiP, PDIA4, HSP90B1, ERP29, and CALR also being secreted. PDIA4 emerged as a central player: its depletion significantly impaired FLS proliferation and migration, highlighting a direct role in driving synovitis. This study provides the first spatial and functional characterization of ER chaperones in human arthritic synovium, linking ER stress to fibroblast plasticity, inflammation, and fibrosis.
- Open Access
CXCR4 antagonism restores dendritic cell migration and activation in a WHIM syndrome mouse model
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a primary immunodeficiency caused by gain-of-function in CXCR4 chemokine receptor (CXCR4 GOF ) in response to its chemokine ligand CXCL12. The patients suffering from this syndrome display lymphopenia and neutropenia, and most of them show exacerbated susceptibility to human papillomavirus pathogenesis. In a mouse model harboring a WHIM-associated CXCR4 mutation and expressing HPV16 oncoproteins in keratinocytes, we previously reported reduced circulating plasmacytoid dendritic cells (pDCs), mirroring patients’ blood, and impaired dendritic cell (DC) trafficking from the skin to lymphoid organs, with the few migrating DCs displaying an overactivated phenotype. Given the promising results of CXCR4-targeted therapies in WHIM patients, we investigated whether and how the orally available CXCR4-specific antagonist, X4-136, affects DC localization, activation, and trafficking at the subset level, as well as skin immune landscape. CXCR4 GOF inhibition corrected defects in circulating myeloid cells and pDCs, as well as in lymph node-resident DCs. Furthermore, it rescued skin DC migration to lymph nodes in WHIM mice, in a context- and subset-dependent manner, by promoting their activation and relocation within the dermis. Taken together, these findings indicate that inhibiting CXCR4 GOF may restore skin immunity in WHIM syndrome by rescuing DC counts and functions. Key points: CXC R4 gain-of-function inhibition promotes subset-selective dermal dendritic cell migration to lymph nodes in a WHIM syndrome mouse model. Inhibiting CXCR4 corrects migratory WHIM dendritic cell hyperactivation with subset-specific effects tied to the inflammatory context.
Open AccessCXCR4 antagonism restores dendritic cell migration and activation in a WHIM syndrome mouse model
WHIM (warts, hypogammaglobulinemia, infections, and myelokathexis) syndrome is a primary immunodeficiency caused by gain-of-function in CXCR4 chemokine receptor (CXCR4 GOF ) in response to its chemokine ligand CXCL12. The patients suffering from this syndrome display lymphopenia and neutropenia, and most of them show exacerbated susceptibility to human papillomavirus pathogenesis. In a mouse model harboring a WHIM-associated CXCR4 mutation and expressing HPV16 oncoproteins in keratinocytes, we previously reported reduced circulating plasmacytoid dendritic cells (pDCs), mirroring patients’ blood, and impaired dendritic cell (DC) trafficking from the skin to lymphoid organs, with the few migrating DCs displaying an overactivated phenotype. Given the promising results of CXCR4-targeted therapies in WHIM patients, we investigated whether and how the orally available CXCR4-specific antagonist, X4-136, affects DC localization, activation, and trafficking at the subset level, as well as skin immune landscape. CXCR4 GOF inhibition corrected defects in circulating myeloid cells and pDCs, as well as in lymph node-resident DCs. Furthermore, it rescued skin DC migration to lymph nodes in WHIM mice, in a context- and subset-dependent manner, by promoting their activation and relocation within the dermis. Taken together, these findings indicate that inhibiting CXCR4 GOF may restore skin immunity in WHIM syndrome by rescuing DC counts and functions. Key points: CXC R4 gain-of-function inhibition promotes subset-selective dermal dendritic cell migration to lymph nodes in a WHIM syndrome mouse model. Inhibiting CXCR4 corrects migratory WHIM dendritic cell hyperactivation with subset-specific effects tied to the inflammatory context.
- 23 January 2026
- Published by Elsevier in Laboratory Investigation
- Vol. 106 (3) , 106075
Optimal Formalin-Fixed Paraffin-Embedded Sample Preservation for Efficient Staining in Multiplex Imaging
- 23 January 2026
- Published by Elsevier in Laboratory Investigation
- Vol. 106 (3) , 106075
Optimal Formalin-Fixed Paraffin-Embedded Sample Preservation for Efficient Staining in Multiplex Imaging
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 6. Cell densities in cSCC from different clinical situations.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 6. Cell densities in cSCC from different clinical situations.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S8 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 8. Cell densities in cSCC from primary cSCC and relapsing cSCC from paired patients.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 8. Cell densities in cSCC from primary cSCC and relapsing cSCC from paired patients.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Table S5 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Table 5. Statistical differences between the density of the immune cell subsets infiltrating NT epidermis
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Table 5. Statistical differences between the density of the immune cell subsets infiltrating NT epidermis
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 5. Neighborhood analysis in perilesional NT skin and in cSCC.
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Figure 5. Neighborhood analysis in perilesional NT skin and in cSCC.
- Open Access
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Table 3. 39-markers IMC panel for cSCC TiME characterization
- 2 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from CD206+CD14− Skin-Resident Macrophages and DC–T Cell Clusters Are Spatial Features Characterizing Nonrelapsing Cutaneous Squamous Cell Carcinoma
Supplementary Table 3. 39-markers IMC panel for cSCC TiME characterization